News

myTomorrows Raises $29 Million to Scale and Transform Access to Innovative Therapies for Patients Worldwide

Investment by Avego will extend reach, accelerate AI innovation, and deepen industry partnerships. AMSTERDAM, Nov. 11, 2025 /PRNewswire/ -- myTomorrows,…

2 months ago

Mentavi Health Introduces “Mentavi Concierge” – Setting a New Standard for Responsible AI in Digital Health

Built for trust and compliance, the AI support assistant streamlines intake and routes visitors and patients to human‑led care. GRAND…

2 months ago

SoftWriters Launches Alpha Labs Team to Advance AI and Automation Innovation

New cross-functional "Alpha Labs" team will fast-track AI and automation capabilities from concept to product, helping long-term care pharmacies work…

2 months ago

Cosmo’s ESG Rating Upgraded by S&P Global; Strengthens Supplier Sustainability Oversight Engagement, and Italian Manufacturing Plant Awarded EcoVadis Bronze Medal

Dublin, Ireland--(Newsfile Corp. - November 11, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and…

2 months ago

CardioComm Receives TSX Venture Exchange Approval for Announced Loan Facility

Funding will be used to a advance GEMS Flex And 14-Day Holter/LTCM ECG PlatformToronto, Ontario--(Newsfile Corp. - November 10, 2025)…

2 months ago

LevelJump Announces 2025 Third Quarter Results

Toronto, Ontario--(Newsfile Corp. - November 10, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company") is pleased to announce its…

2 months ago

CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025

SAN DIEGO, CALIFORNIA / ACCESS Newswire / November 10, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our",…

2 months ago

CV Sciences, Inc. to Announce Third Quarter 2025 Results on November 13, 2025

SAN DIEGO, CALIFORNIA / ACCESS Newswire / November 10, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our",…

2 months ago

FACT’s New Standards for Immune Effector Cells in the Community Clinical Setting Help Bring Cell Therapies Closer to Patients

Consensus-Built ‘Fit-for-Purpose' Quality and Safety Standards for Community Oncology Programs OMAHA, NEBRASKA / ACCESS Newswire / November 10, 2025 /…

2 months ago

FACT’s New Standards for Immune Effector Cells in the Community Clinical Setting Help Bring Cell Therapies Closer to Patients

Consensus-Built ‘Fit-for-Purpose' Quality and Safety Standards for Community Oncology Programs OMAHA, NEBRASKA / ACCESS Newswire / November 10, 2025 /…

2 months ago